Compare Halozyme Therapeutics Inc. Common Stock (HALO) vs Planet Labs (PL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Halozyme Therapeutics Inc. Common Stock vs Planet Labs — how do they compare? Halozyme Therapeutics Inc. Common Stock trades at $110.89 (market cap $12.58B), while Planet Labs trades at $17.23 (market cap $6.25B). The key difference: Halozyme Therapeutics Inc. Common Stock is far larger — about 2× Planet Labs's market cap, and Halozyme Therapeutics Inc. Common Stock is trading nearer its 52-week high, Planet Labs nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Halozyme Therapeutics Inc. Common Stock for 0 Days and Planet Labs for 4 Days on average.
| HALO | PL | |
|---|---|---|
Market Cap | $12.58B | $6.25B |
Volume | 2,179,278 | 19,125,340 |
Sector | Health | Industrials |
52-Week High | $115.22 | $51.40 |
52-Week Low | $61.63 | $11.16 |
Typical Hold Time | 0 Days | 4 Days |
Enterprise Value | $14.49B | $5.89B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Halozyme Therapeutics Inc. Common Stock
Halozyme Therapeutics develops drug-delivery technologies for biopharmaceutical companies. Its ENHANZE technology uses the rHuPH20 enzyme to support subcutaneous delivery of co-administered medicines.
Read more on HALO →About Planet Labs
Planet Labs operates Earth-imaging satellites and provides geospatial data products. Its imagery and analytics help governments and businesses monitor changes across the planet.
Read more on PL →
